Drug Profile
Research programme: Parkinson's disease therapeutics - Peptimmune
Alternative Names: DEEP-PDLatest Information Update: 29 Aug 2011
Price :
$50
*
At a glance
- Originator Peptimmune
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Parkinson's disease